Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by PVR is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. Additionally we are shipping Poliovirus Receptor Antibodies (125) and Poliovirus Receptor Proteins (26) and many more products for this protein.
Showing 1 out of 4 products:
implying that TIGIT (show TIGIT ELISA Kits) exerts immunosuppressive effects by competing with DNAM-1 (show CD226 ELISA Kits) for the same ligand, CD155
The present study provides evidence that regulation of the PVR/CD155 DNAM-1 (show CD226 ELISA Kits) ligand expression by nitric oxide may represent an additional immune-mediated mechanism and supports the anti-myeloma activity of nitric oxide donors.
Our findings suggest that loss of CD155 expression may play an important role in the immune escape of HCC (show FAM126A ELISA Kits) cells and thus CD155 may serve as a prognostic marker as well as a potential therapeutic target for HCC (show FAM126A ELISA Kits).
CD155 may play a critical role through both immunological and non-immuno logical mechanisms in pancreatic cancer and may be a therapeutic target for this intractable malignancy.
CD155 (PVR/Necl5) mediates a costimulatory signal in CD4 (show CD4 ELISA Kits)+ T cells and regulates allergic inflammation.
The cell-surface receptor (Pvr) catalyzes a large structural change in the poliovirus that exposes membrane-binding protein chains.
UPR decreases CD226 (show CD226 ELISA Kits) ligand CD155 expression and sensitivity to NK cell-mediated cytotoxicity in hepatoma cells.
Ala residues 10, 14 and 18 in the TM domain of Vpu are required for CD155 downregulation.
TIGIT (show TIGIT ELISA Kits)/PVR ligation signaling mediates suppression of IFN-gamma (show IFNG ELISA Kits) production via the NF-kappaB (show NFKB1 ELISA Kits) pathway.
UL141 can inhibit cell-surface expression of both natural killer (NK) cell-activating ligand CD155 as well as TRAIL death receptors (TRAIL-R1 and TRAIL-R2 (show TNFRSF10B ELISA Kits)).
Results suggest that modulation of the expression of receptors and CD112 (show PVRL2 ELISA Kits) compensates for CD155 deficiency in immune surveillance against methylcholanthrene-induced tumors.
Sertoli cells recognize the excess cytoplasm of elongated spermatids through the PVR-CEACAM2-L interaction in mouse testis
TIGIT (show TIGIT ELISA Kits)/PVR (show PVRL2 ELISA Kits) ligation signaling mediates suppression of IFN-gamma (show IFNG ELISA Kits) production via the NF-kappaB (show NFKB1 ELISA Kits) pathway.
Our data suggest that CD155 regulates T(h)2 differentiation
These observations establish a firm link between the functions of CD155 and CD226 (show CD226 ELISA Kits) in several T cell differentiation steps.
Necl-5/poliovirus receptor interacts with VEGFR2 (show KDR ELISA Kits) and regulates VEGF (show VEGFA ELISA Kits)-induced angiogenesis.
The TLR3 (show TLR3 ELISA Kits)-TRIF (show RNF138 ELISA Kits) mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice.
Necl-5 plays a role in the attraction of growing MTs (show NEU2 ELISA Kits) to the plasma membrane of the leading edge of moving cells.
Newly matured CD8 (show CD8A ELISA Kits)-positive thymocytes cannot be retained in the thymic medulla when CD155 expression is missing. Mature cells emigrate prematurely when CD155 is absent, cutting short their retention time in the thymic medulla.
The protein encoded by this gene is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. The external domain mediates cell attachment to the extracellular matrix molecule vitronectin, while its intracellular domain interacts with the dynein light chain Tctex-1/DYNLT1. The gene is specific to the primate lineage, and serves as a cellular receptor for poliovirus in the first step of poliovirus replication. Multiple transcript variants encoding different isoforms have been found for this gene.
, nectin-like 5
, nectin-like protein 5
, tumor-associated antigen 1
, tumor-associated glycoprotein pE4